Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome H Kim

Showing results (1-10 of 294) with videos related to

Pageof 30
Sort By:
The Journal of Experimental Medicine|October 16, 2020
SARS-CoV-2 vaccine development, access, and equityJerome H Kim
The New England Journal of Medicine|July 29, 2016
A Challenge in Vaccine Development--Neisseria meningitidis Serogroup BJerome H Kim
Human Vaccines & Immunotherapeutics|January 15, 2016
ProfileJerome H Kim
Nature Communications|February 12, 2026
Publisher Correction: Strengthening vaccine capacity building on the African continentNicaise Ndembi, Jerome H Kim
Nature Medicine|May 20, 2026
Global vaccine developmentJerome H Kim, Nicaise Ndembi
The Lancet. Infectious Diseases|April 24, 2020
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?Kayvon Modjarrad, Jerome H Kim
The New England Journal of Medicine|December 5, 2019
Parting the Clouds over Typhoid with a New Conjugate VaccineFlorian Marks, Jerome H Kim
The Lancet. Infectious Diseases|July 29, 2019
First clinical trial of a MERS coronavirus DNA vaccineIn-Kyu Yoon, Jerome H Kim
Clinical and Experimental Vaccine Research|August 5, 2016
Accelerating the development of a group A Streptococcus vaccine: an urgent public health needJean-Louis Excler, Jerome H Kim
Current Opinion in HIV and AIDS|September 9, 2016
HIV vaccines moving forwardStephen J Kent, Jerome H Kim
Pageof 30

Showing results (1-10 of 294) with videos related to

Sort By:
Pageof 30
The Journal of Experimental Medicine|October 16, 2020
SARS-CoV-2 vaccine development, access, and equityJerome H Kim
The New England Journal of Medicine|July 29, 2016
A Challenge in Vaccine Development--Neisseria meningitidis Serogroup BJerome H Kim
Human Vaccines & Immunotherapeutics|January 15, 2016
ProfileJerome H Kim
Nature Communications|February 12, 2026
Publisher Correction: Strengthening vaccine capacity building on the African continentNicaise Ndembi, Jerome H Kim
Nature Medicine|May 20, 2026
Global vaccine developmentJerome H Kim, Nicaise Ndembi
The Lancet. Infectious Diseases|April 24, 2020
Two Middle East respiratory syndrome vaccines: first step for other coronavirus vaccines?Kayvon Modjarrad, Jerome H Kim
The New England Journal of Medicine|December 5, 2019
Parting the Clouds over Typhoid with a New Conjugate VaccineFlorian Marks, Jerome H Kim
The Lancet. Infectious Diseases|July 29, 2019
First clinical trial of a MERS coronavirus DNA vaccineIn-Kyu Yoon, Jerome H Kim
Clinical and Experimental Vaccine Research|August 5, 2016
Accelerating the development of a group A Streptococcus vaccine: an urgent public health needJean-Louis Excler, Jerome H Kim
Current Opinion in HIV and AIDS|September 9, 2016
HIV vaccines moving forwardStephen J Kent, Jerome H Kim
Pageof 30